Aarey Drugs & Pharmaceuticals is currently trading at Rs 75.45, up by 2.85 points or 3.93% from its previous closing of Rs. 72.60 on the BSE.
The scrip opened at Rs. 72.60 and has touched a high and low of Rs. 76.00 and Rs. 72.25 respectively. So far 348337 shares were traded on the counter.
The BSE group 'XD' stock of face value Rs. 10 has touched a 52 week high of Rs. 76.00 on 02-Feb-2017 and a 52 week low of Rs. 16.30 on 12-Feb-2016.
Last one week high and low of the scrip stood at Rs. 76.00 and Rs. 65.55 respectively. The current market cap of the company is Rs. 131.58 crore.
The promoters holding in the company stood at 54.94%, while Institutions and Non-Institutions held 0.12% and 44.95% respectively.
Aarey Drugs & Pharmaceuticals has bagged orders worth Rs 50 crore for Iodine and Bromine based intermediate used for manufacturing of pharma intermediates, up to March 2017.
Aarey Drugs & Pharmaceuticals is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.
| Company Name | CMP |
|---|---|
| Redington | 278.85 |
| Amrapali Industries | 40.20 |
| Adani Enterprises | 3026.00 |
| Rashi Peripheral | 773.90 |
| PDS | 340.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: